2月27日，优利德跌0.44%，成交额5746.95万元，换手率1.21%，总市值47.65亿元。 异动分析 来源：新浪证券-红岸工作室 芯片概念+人民币贬值受益+光伏概念+核污染防治+PM2.5 1、2023年年报：针对数字示波器前端的专用芯片，公司采取合作研发模式，目前已成功研发并发布多 款芯片产品，拥有自主知识产权，实现关键零部件自主可控。报告期内，公司完成了 VG500、FG10、 FD10三款示波器前端芯片的设计、流片及验证。 公司计划从 2024 年开始陆续将上述专用芯片应用到 公司生产的新一代示波器产品中。 2、根据2024年年报，公司海外营收占比为54.72%，受益于人民币贬值。 3、2023年年报，公司已推出专业光伏钳形表，光伏组件最大功率测试仪产品，并计划在 2024 年推出最 大测试功率 15kW 的多功能光伏 I-V 曲线测试仪。 今日主力净流入77.97万，占比0.01%，行业排名72/245，该股当前无连续增减仓现象，主力趋势不明 显；所属行业主力净流入-13.11亿，当前无连续增减仓现象，主力趋势不明显。 区间今日近3日近5日近10日近20日主力净流入77.97万-1190.66 ...

Core Viewpoint - The news summarizes important announcements from various companies, highlighting significant developments in their operations and financial performance. Company Announcements - Tianfeng Securities received a notice from the China Securities Regulatory Commission regarding a case of information disclosure violation related to Fujian Yong'an Forestry Group, and the company will cooperate with the investigation [3] - Southwest Securities plans to raise no more than 6 billion yuan through a private placement to supplement its capital and optimize its capital structure [4] - Qiaoyin Co. has terminated its investment in the artificial intelligence industry headquarters project due to changes in cooperation conditions, with a planned investment of no more than 1 billion yuan [5] - Zongshen Power is planning a major asset swap with Longxin General, aiming to resolve competition issues and promote clearer business development [6] - Laimei Pharmaceutical's selected products for national centralized procurement are expected to generate 106 million yuan in sales for 2024, accounting for 13.35% of the company's revenue [7] Performance Reports - Huayin Technology reported a net profit of 313 million yuan for 2025, a decrease of 24.28%, with revenue of 1.251 billion yuan, up 9.83% [9] - Youlide announced a net profit of 152 million yuan for 2025, down 16.88%, with revenue of 1.221 billion yuan, up 7.99% [10][11] - Fudan Microelectronics reported a net profit of 232 million yuan for 2025, a decline of 59.42%, with revenue of 3.982 billion yuan, up 10.92% [12] - Hanzhong Precision reported a net profit of 470 million yuan for 2025, down 45.54%, with revenue of 2.928 billion yuan, a decrease of 20.32% [13] Shareholding Changes - Gaomei Co.'s controlling shareholder and several directors plan to reduce their holdings by up to 3.19% of the company's shares [15] - Guanghuan New Network's controlling shareholder intends to reduce its stake by up to 3% [16] - ST Yigou's shareholder plans to reduce its holdings by up to 2.5% [17] - Juguang Technology's shareholders plan to collectively reduce their holdings by up to 2.3339% [18] - Xiandai Jidian's shareholder intends to reduce its stake by up to 2.05% [19] - Zhejing Pharmaceutical's shareholders plan to reduce their holdings by up to 1.0385% [21] Contract Signings - China Nuclear Construction signed contracts worth 3.393 billion yuan in January, with total revenue of 7.69 billion yuan [23] - China Chemical signed contracts totaling 36.925 billion yuan in January, including significant contracts over 500 million yuan [24]

Group 1 - RuiLian New Materials reported a total operating revenue of 1.677 billion yuan for 2025, an increase of 14.95% year-on-year, with a net profit of 311 million yuan, up 23.48% year-on-year [1] - China Shenhua's subsidiary, Guoneng Qingyuan Power, successfully put its fourth generator unit into commercial operation, expected to provide approximately 20 billion kWh of clean energy annually [2] - Qijiang Airlines announced a 6.04% year-on-year decline in passenger turnover for January 2026, with a passenger load factor of 84.03%, up 1.61% year-on-year [3] Group 2 - QiZheng Tibetan Medicine reported a total operating revenue of 2.416 billion yuan for 2025, a year-on-year increase of 3.34%, with a net profit of 646 million yuan, up 10.98% year-on-year [5] - QiaoYin Co. announced the termination of its artificial intelligence industry headquarters project due to changes in investment cooperation conditions [6] - New Point Software plans to use 90.81 million yuan of surplus raised funds for new projects, including AI-driven software development [7] Group 3 - High Measurement Co. announced plans for major shareholders and executives to reduce their holdings by up to 3.19% of the company's shares [8] - SAIC Group's subsidiary plans to establish a private equity fund with an initial scale of 2.5 billion yuan, focusing on solid-state batteries and chip localization [9] - Tianqi Lithium announced the resignation of its deputy general manager due to personal career planning [10] Group 4 - ZhongKong Technology reported a total operating revenue of 8.051 billion yuan for 2025, a decrease of 11.90%, with a net profit of 450 million yuan, down 59.70% year-on-year [11] - Spring Airlines reported a 6.28% year-on-year increase in total passenger volume for January 2026, with a total available ton-kilometers of 57,008.37 [12] - Qifan Cable's controlling shareholder reduced its stake by 3% through various trading methods [13] Group 5 - China Chemical signed contracts worth a total of 36.925 billion yuan in January 2026, with significant contracts exceeding 5 billion yuan totaling 11.371 billion yuan [19] - SaiTuo Bio received a CEP certificate for its raw material drug Betamethasone, which is used to treat allergies and autoimmune inflammation [20] - Giant Star Agriculture reported a sales revenue of 649 million yuan from commodity fat pigs in January 2026, with a sales volume of 404,400 pigs [23] Group 6 - Qinglong Pipe Industry's subsidiary won a 146 million yuan pipeline project [24] - Changshan Pharmaceutical announced that some of its products are expected to be selected for national centralized procurement [26] - Yangdian Technology completed the transfer of 12.96% of its shares through an agreement [27] Group 7 - Deepin Technology's investment fund introduced new limited partners and adjusted the capital contributions of some partners [28] - Qingyun Technology plans to pledge 25% of its shares for a loan application of up to 30 million yuan [29] - LaiMei Pharmaceutical reported a 57.20% year-on-year decline in net profit for 2025 [30] Group 8 - YouLiDe reported a 16.88% year-on-year decline in net profit for 2025, with total operating revenue of 1.221 billion yuan, up 7.99% [31] - Warner Pharmaceutical reported a net profit of 241 million yuan for 2025, an increase of 46.95% year-on-year [32] - LianRui New Materials reported a net profit of 293 million yuan for 2025, an increase of 16.42% year-on-year [33] Group 9 - HuaQin Technology expects a 24.28% year-on-year decrease in net profit for 2025, with projected revenue of 1.251 billion yuan, up 9.83% [34] - QiPai Technology's shareholder subscribed for 6.3 million shares, accounting for 5.49% of the total share capital [35] - Qilin Security's shareholders completed their planned share reductions without exceeding the original plan [36] Group 10 - Dameng Data announced the lifting of the detention of its senior vice president, allowing him to resume his duties [37] - Haiyou Engineering won a contract for the "NFPS COMP5" project worth approximately 4 billion USD, with the company's share exceeding 800 million USD [38] - Yatai Group plans to sell 20.81% of its shares in Northeast Securities, pending confirmation of financial statements [39]

为应对国际贸易环境变化，公司在越南投资建设了生产基地，前期产能爬坡对当期利润构成较大影响。 2025年第四季度，越南生产基地已实现正常生产及批量交货。 格隆汇2月13日丨优利德(688628.SH)公布2025年度业绩快报，报告期内，公司2025年度实现营业收入 12.21亿元，同比增长7.99%；实现归属于母公司所有者的净利润1.52亿元，同比下降16.88%；实现归属 于母公司所有者的扣除非经常损益的净利润1.47亿元，同比下降16.59%。 ...

为应对国际贸易环境变化，公司在越南投资建设了生产基地，前期产能爬坡对当期利润构成较大影响。 2025年第四季度，越南生产基地已实现正常生产及批量交货。 格隆汇2月13日丨优利德(688628.SH)公布2025年度业绩快报，报告期内，公司2025年度实现营业收入 12.21亿元，同比增长7.99%；实现归属于母公司所有者的净利润1.52亿元，同比下降16.88%；实现归属 于母公司所有者的扣除非经常损益的净利润1.47亿元，同比下降16.59%。 ...

优利德(688628.SH)发布2025年度业绩快报，报告期内，公司2025年度实现营业收入12.21亿元，同比增 长7.99%;实现归属于母公司所有者的净利润1.52亿元，同比下降16.88%。 ...

证券代码：688628 证券简称：优利德 公告编号：2026-002 优利德科技（中国）股份有限公司 2025年度业绩快报公告 1、经营情况、财务状况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载 2025 年度主要财务数据为初步核算数据，未经会计师事务所审 计，具体数据以优利德科技（中国）股份有限公司（以下简称"公司"）2025 年年度的定期报告为准，提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位：元 | 项目 | 本报告期 | 上年同期 | 增 减 变 （％） | 动 幅 度 | | --- | --- | --- | --- | --- | | 营业总收入 | 1,220,761,538.05 | 1,130,401,616.57 | | 7.99 | | 营业利润 | 149,961,737.66 | 201,063,541.91 | | -25.42 | | 利润总额 | 148,538,923.59 | 200,333,403.02 | | -25.85 | | 归属于母公司所 ...

Core Viewpoint - The company, Youlide Technology, is experiencing a decline in stock price and trading volume, while also benefiting from various market trends such as RMB depreciation and advancements in solar and chip technologies [1][4]. Financial Performance - For the period ending September 30, 2025, Youlide achieved a revenue of 923 million yuan, representing a year-on-year growth of 8.10% [7]. - The net profit attributable to the parent company was 135 million yuan, showing a year-on-year decrease of 10.87% [8]. - The company has distributed a total of 402 million yuan in dividends since its A-share listing, with 320 million yuan distributed over the past three years [9]. Market Position and Trends - As of February 4, the company's stock price decreased by 1.99%, with a total market capitalization of 4.139 billion yuan [1]. - The company has a significant overseas revenue contribution of 54.72%, benefiting from the depreciation of the RMB [2]. - The company has launched a professional photovoltaic clamp meter and plans to introduce a multifunctional photovoltaic I-V curve tester with a maximum testing power of 15kW in 2024 [2]. Product Development - Youlide has adopted a collaborative R&D model for specialized chips used in digital oscilloscopes, successfully developing several chip products with independent intellectual property rights [2]. - The company has completed the design, tape-out, and verification of three front-end chips for oscilloscopes, with plans to integrate these chips into new generation oscilloscope products starting in 2024 [2]. Industry Context - Youlide operates in the mechanical equipment sector, specifically in the general equipment and instrument industry, with its main business segments including general instruments (55.97%), temperature and environmental testing instruments (19.20%), testing instruments (14.16%), and specialized instruments (10.20%) [7]. - The company is associated with several concept sectors, including photovoltaic glass, instrument and meter concepts, small-cap growth, and chip concepts [7].

董事减持股份结果公告 证券代码：688628 证券简称：优利德 公告编号：2026-001 优利德科技（中国）股份有限公司 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 ■ 注：上述持股比例是按公司当时总股本111,742,888股进行计算。 上述减持主体无一致行动人。 重要内容提示： ● 董事持有的基本情况 本次减持计划实施前，优利德科技（中国）股份有限公司（以下简称"公司"）董事、核心技术人员杨志 凌先生直接持有公司股份28,980股，占公司总股本的0.0259%；董事、核心技术人员孙乔先生直接持有 公司股份8,400股，占公司总股本的0.0075%；职工董事、副总经理、董事会秘书周建华先生直接持有公 司股份50,900股，占公司总股本的0.0455%；董事、副总经理、财务总监张兴先生直接持有公司股份 51,200股，占公司总股本的0.0458%。上述股份来源为股权激励取得，均为无限售条件流通股。 ● 减持计划的实施结果情况 公司于2025年12月1日披露了《董事减持股份计划公告》（公告编号2025-058 ...

证券代码：688628 证券简称：优利德 公告编号：2026-001 优利德科技（中国）股份有限公司 董事减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 董事持有的基本情况 本次减持计划实施前，优利德科技（中国）股份有限公司（以下简称"公司"） 董事、核心技术人员杨志凌先生直接持有公司股份 28,980 股，占公司总股本的 0.0259%；董事、核心技术人员孙乔先生直接持有公司股份 8,400 股，占公司总 股本的 0.0075%；职工董事、副总经理、董事会秘书周建华先生直接持有公司股 份 50,900 股，占公司总股本的 0.0455%；董事、副总经理、财务总监张兴先生 直接持有公司股份 51,200 股，占公司总股本的 0.0458%。上述股份来源为股权 激励取得，均为无限售条件流通股。 减持计划的实施结果情况 公司于 2025 年 12 月 1 日披露了《董事减持股份计划公告》（公告编号 2025-058），董事、核心技术人员杨志凌先生计划通过集中竞价交易方式减持不 超过 ...